Letting some air out of the AMP inflation penalty.As of late, we have all been bombarded by headlines lamenting or explaining the recent high inflation rates as we consume our daily news. The default reaction to rising inflation is typically in relation to rising...
Three things to know about the challenges of VA/FSS contracting.The Veterans/Federal Supply Schedule (VA/FSS) is likely the most complex and time-consuming government contracting process you will face. Public Law 102-585 requires brand manufacturers to participate in...
Understanding Baseline AMP Rules Can Help You Avoid Pricing Decision DisastersWhat brand and generic drug manufacturers need to knowA lack of understanding respective to baseline Average Manufacturer Price (AMP) and how it can affect your Medicaid pricing can result...
Understanding the complexities of implementing a generic pharmaceutical company commercialization plan.Seasoned pharma executives know that implementing a generic pharmaceutical company commercialization plan in the US market is a complex exercise in multi-tasking....
Why Medicaid is a pharma company’s most demanding government program in terms of potential impact and resources.For both brand and generic pharma companies, the most demanding of the government programs, in terms of financial impact and required resources, is often...
Avoiding Costly Government Pricing MistakesBasic steps pharmaceutical manufacturers should employ to avoid erroneous government pricing calculationsManaging Government Pricing (GP) computations can feel a bit like walking through a cave without a flashlight. Even an...